tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
VYNE
VYNE Therapeutics
RESEARCH TOOLSreports
Want to see VYNE full AI Analyst Report?

VYNE Therapeutics (VYNE) Financial Statements

1,903 Followers

VYNE Therapeutics Financial Overview

VYNE Therapeutics's market cap is currently $22.01M. The company's EPS TTM is $-0.62; its P/E ratio is -1.28; VYNE Therapeutics is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 570.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Gross Profit$ 547.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Operating Income$ -29.75M$ -43.64M$ -29.26M$ -34.30M$ -38.91M
EBITDA$ -26.73M$ -43.63M$ -29.26M$ -34.22M$ -38.80M
Net Income$ -26.48M$ -39.83M$ -28.45M$ -23.21M$ -73.33M
Balance Sheet
Cash & Short-Term Investments$ 29.01M$ 61.52M$ 93.25M$ 30.91M$ 42.25M
Total Assets$ 30.16M$ 66.91M$ 97.69M$ 40.76M$ 67.05M
Total Debt$ 0.00$ 99.00K$ 214.00K$ 0.00$ 349.00K
Net Debt$ -24.03M$ -19.83M$ -30.41M$ -30.91M$ -41.90M
Total Liabilities$ 2.40M$ 14.82M$ 8.95M$ 9.56M$ 18.41M
Stockholders' Equity$ 27.77M$ 52.09M$ 88.73M$ 31.20M$ 48.64M
Cash Flow
Free Cash Flow$ -33.12M$ -34.09M$ -25.34M$ -29.20M$ -56.37M
Operating Cash Flow$ -33.12M$ -33.97M$ -25.34M$ -29.20M$ -56.37M
Investing Cash Flow$ 37.37M$ 23.36M$ -57.35M$ 15.67M$ 1.03M
Financing Cash Flow$ -143.00K$ -141.00K$ 82.39M$ 1.65M$ 39.78M
Currency in USD

VYNE Therapeutics Earnings and Revenue History

Income Statement >

VYNE Therapeutics Debt to Assets

Balance Sheet >

VYNE Therapeutics Cash Flow

Cash Flow >

VYNE Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >